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Rac1, caveolin-1 and vascular endothelial growth factor-mediated liver sinusoidal
endothelial cell angiogenesis
Rac1 and cell morphogenesis
In this issue of Liver International, Yokomori et al. (1) detailed
howRac1, a memberof the Rho-GTPases protein family,playsa
key role in the migration of liver sinusoidal endothelial cells
(LSECs) and in the subsequent process of capillary-like tubular
formation (i.e. endothelial cell differentiation). The family of
Rho-GTPases, thanks to their capacity to regulate actin cytos-
keleton dynamics, generally control a wide range of cellular
processes, such as cell proliferation, differentiation, motility,
membrane transport and cell permeability (2). In ﬁbroblasts
and microvascular endothelial cells, Cdc42 produces micro-
spikes and ﬁlopodia, Rac1 induces rufﬂes and lamellipodia, and
RhoA promotes stress-ﬁbre formation. The same research
group demonstrated the role of RhoA in LSECs in controlling
the fenestral diameter (3) – the fenestrae are open, membrane-
bound pores surrounded by a cytoskeletal ring that control the
extensive exchange between the liver sinusoidal blood and the
hepatocytes. In the present study, Yokomori et al. show in
cultured LSECs that Rac1 activity markedly increases with time
after continuing exposure to vascular endothelial growth factor
(VEGF). In addition, the authors present the ﬁrst molecular
and structural evidence that Rac1 mediates the formation of
capillary-like tubular structures when LSECs were exposed to
VEGF and grown on matrigel as the cell-culture substrate. The
authors postulated that this peculiar cellular rearrangement of
LSECs is the ﬁrst morphological sign of LSEC differentiation,
and as such the structural precursor in the complex cascade of
LSEC angiogenesis (vide infra). Hence, reviewing Yokomori’s
data in light of the recent Rho-GTPases (Rho, Rac and Cdc42)
angiogenesis ﬁndings byothers [for a review, see (4)], illustrates
not only the novelty of the data but also highlight that LSEC-
associated Rho-GTPases might serve as potential molecular
targets for treating diseases in which the liver sinusoidal
microvasculature plays some major role. For example, the
function of Rho-GTPases, or their related downstream effector
molecules, are involved in the processes of primary or second-
ary liver cancer, liver cirrhosis and hepatitis (5). These are all
important and severe clinical conditions in which the liver
sinusoidal microcirculation is central. Potential therapeutic
approaches – involving switching on or off a GTPases-mediated
signal-transduction chain – have been recently discussed,
reviewed and published in other relevant pathological settings
such as cancer (6) and neuro-related diseases (7).
Caveolin-1 and angiogenesis
Interestingly, the authors also observe a concurrent time-
dependent increase in caveolin-1 (Cav-1) levels in their experi-
mental setup, indicating that this membrane protein might
also be an essential molecular modulator in the process of
LSEC capillary-tube formation. Indeed, although all types of
caveolins (Cav-1, Cav-2 and Cav-3) are similar in structure
and associate with cholesterol and sphingolipids in certain areas
of the cell membrane, leading to the formation of caveolae,
Cav-1 is most prominently expressed in endothelial cells
and ﬁbrosblasts (8). The recent data of Grande-Garci´ a and Del
Pozo (9) directly support the Cav-1 ﬁndings of Yokomori et al.,
as the Cav-1 and Rho GTP-ases proteins (vide supra) are closely
involved in cell polarization and directional migration of
ﬁbroblasts (10). In view of this, it is reasonable to suggest
that the same cascade of molecular networks will occur in the
liver sinusoidal endothelium. It is also noteworthy that LSEC-
associated Cav-1 facilitates liver sinusoidal transendothelial
transport (11) and promotes in one or another way the
onset of fenestrae (12). Yokomori and colleagues postulate
that LSEC-associated Cav-1 has another pivotal function as a
regulator of LSEC proliferation, a necessary step in the process
of angiogenesis. Taking all the functions of LSEC Cav-1
together, it is clear that complex Cav-1 cross-talk signal path-
ways must be present within the liver sinusoidal endothelial
lining. Indeed, cell-type-speciﬁc complex Cav-1 regulatory
pathways exist that regulate the multiple functions of this
membrane-associated protein [for a review, see (13)]. Cur-
rently, however, it remains to be seen how LSECs manage to
control the balance between Cav-1-mediated transport and
Cav-1-mediated cell migration and/or proliferation, or whether
both occur in harmony.
Caveolin-1, Rho family GTPases and vascular
endothelial growth factor-induced angiogenesis
Migration of endothelial cells, induced by VEGF, is a critical step
in angiogenesis and the Rac GTPase is known to be the critical
molecular intersection during stimulation of endothelial-cell
motility (4, 14). On the other hand, VEGF is a well-known,
potent inducer of caveolae in microvascular endothelium
(12, 15). Moreover, it has been shown that Cav-1 expression
enhances formation of endothelial capillary tubules in micro-
vascular endothelial cells (16), and manipulating Cav-1 expres-
sion, or negatively interfering with caveolae formation, adversely
affects cell migration (9, 17). By using wild-type vs. Cav-1
/ cell
models, it has been demonstrated that Cav-1 presents a polarized
distribution during directional migration by coordinating signal-
ling of Src kinase and Rho-GTPase (9, 18, 19). And, last but
not least, a key role for Cav-1 in the process of angiogenesis
has been found (9, 20). As is evident from this brief review of
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process of VEGF-induced LSEC morphogenesis and migration
and/or proliferation is controlled by different signal-transduction
proteins and signalling pathways, the knowledge of which
offers novel targets for the treatment of several liver sinusoidal
endothelial-associated diseases – particularly, diseases where
angiogenesis is central.
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